Bluestein R H & CO LLC Catalent, Inc. Transaction History
Bluestein R H & CO LLC
- $1.61 Billion
- Q3 2022
A detailed history of Bluestein R H & CO LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Bluestein R H & CO LLC holds 4,000 shares of CTLT stock, worth $243,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$243,000
Previous $429,000
32.63%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding CTLT
# of Institutions
514Shares Held
149MCall Options Held
575KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$933 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$453 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$389 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$274 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.9B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...